Spironolactone use and risk of incident cancers: a retrospective, matched cohort study

Aims Spironolactone is widely used to treat heart failure, hypertension and liver disease with increased usage in recent years. Spironolactone has endocrine effects that could influence cancer risks and historical reports suggest possible links with increased risk of certain types of cancer. The aim...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	British journal of clinical pharmacology Ročník 83; číslo 3; s. 653 - 663
Hlavní autoři:	Mackenzie, Isla S., Morant, Steven V., Wei, Li, Thompson, Alastair M., MacDonald, Thomas M.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England John Wiley and Sons Inc 01.03.2017
Témata:	Adult Aged Aged, 80 and over cancer Case-Control Studies cohort study Female Humans Incidence Male Middle Aged Neoplasms - chemically induced Neoplasms - epidemiology Pharmacoepidemiology Proportional Hazards Models prostate Retrospective Studies Risk Factors spironolactone Spironolactone - adverse effects United Kingdom - epidemiology Young Adult cancer prostate cohort study spironolactone pharmacoepidemiology
ISSN:	0306-5251, 1365-2125, 1365-2125
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!